APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Preparation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transdermal Preparation Industry Growth and Trends Forecast to 2032

Report ID 174042620122 December 2025110 pages

Choose your research edition.

Industry ResearchTransdermal Preparation Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Preparation Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Transdermal Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Preparation Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Preparation Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Transdermal Preparation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Preparation include Novastage Pharmaceuticals (Shenzhen), Novartis, Luye Pharma Group, Hunan Jiudian Pharmaceutical, Harbin Hexinotai Pharmaceutical Technology, GSK, Demo Technology, Guangzhou Continent Biomedical Technology and Beijing Tide Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transdermal Preparation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transdermal Preparation market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Preparation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Preparation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transdermal Preparation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transdermal Preparation Market by Company

Novastage Pharmaceuticals (Shenzhen)

Novartis

Luye Pharma Group

Hunan Jiudian Pharmaceutical

Harbin Hexinotai Pharmaceutical Technology

GSK

Demo Technology

Guangzhou Continent Biomedical Technology

Beijing Tide Pharmaceutical

Viatris

Transdermal Corporation

Nitto

MEDRx

Medpharm

ERCO Pharma

4P Therapeutics

Transdermal Preparation Segment by Type

Injectable Preparations

Non Injectable Preparations

Transdermal Preparation Segment by Application

Hospital

Clinic

Other

Transdermal Preparation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Preparation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Preparation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transdermal Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectable Preparations Table 2. Major Company of Non Injectable Preparations Table 3. Global Transdermal Preparation Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 5. Global Transdermal Preparation Sales Market Share in Volume by Type (2021-2026) Table 6. Global Transdermal Preparation Sales by Type (2021-2026) & (US$ Million) Table 7. Global Transdermal Preparation Sales Market Share in Value by Type (2021-2026) Table 8. Global Transdermal Preparation Price by Type (2021-2026) & (US$/unit) Table 9. Global Transdermal Preparation Sales by Type (2027-2032) & (k units) Table 10. Global Transdermal Preparation Sales Market Share in Volume by Type (2027-2032) Table 11. Global Transdermal Preparation Sales by Type (2027-2032) & (US$ Million) Table 12. Global Transdermal Preparation Sales Market Share in Value by Type (2027-2032) Table 13. Global Transdermal Preparation Price by Type (2027-2032) & (US$/unit) Table 14. North America Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 15. North America Transdermal Preparation Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 17. Europe Transdermal Preparation Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Transdermal Preparation Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 21. Latin America Transdermal Preparation Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Transdermal Preparation Sales by Type (2021-2026) & (US$ Million) Table 24. Transdermal Preparation Industry Trends Table 25. Transdermal Preparation Industry Drivers Table 26. Transdermal Preparation Industry Opportunities and Challenges Table 27. Transdermal Preparation Industry Restraints Table 28. Global Transdermal Preparation Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Transdermal Preparation Revenue Market Share by Company (2021-2026) Table 30. Global Transdermal Preparation Sales by Company (2021-2026) & (k units) Table 31. Global Transdermal Preparation Sales Share by Company (2021-2026) Table 32. Global Transdermal Preparation Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Transdermal Preparation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Transdermal Preparation Major Company Production Sites and Headquarters Table 35. Global Transdermal Preparation Company, Product Type & Application Table 36. Global Transdermal Preparation Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Transdermal Preparation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Transdermal Preparation Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Transdermal Preparation Sales by Region (2021-2026) & (k units) Table 41. Global Transdermal Preparation Sales Market Share in Volume by Region (2021-2026) Table 42. Global Transdermal Preparation Sales by Region (2021-2026) & (US$ Million) Table 43. Global Transdermal Preparation Sales Market Share in Value by Region (2021-2026) Table 44. Global Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Transdermal Preparation Sales by Region (2027-2032) & (k units) Table 46. Global Transdermal Preparation Sales Market Share in Volume by Region (2027-2032) Table 47. Global Transdermal Preparation Sales by Region (2027-2032) & (US$ Million) Table 48. Global Transdermal Preparation Sales Market Share in Value by Region (2027-2032) Table 49. Global Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Transdermal Preparation Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 52. Global Transdermal Preparation Sales Market Share in Volume by Application (2021-2026) Table 53. Global Transdermal Preparation Sales by Application (2021-2026) & (US$ Million) Table 54. Global Transdermal Preparation Sales Market Share in Value by Application (2021-2026) Table 55. Global Transdermal Preparation Price by Application (2021-2026) & (US$/unit) Table 56. Global Transdermal Preparation Sales by Application (2027-2032) & (k units) Table 57. Global Transdermal Preparation Sales Market Share in Volume by Application (2027-2032) Table 58. Global Transdermal Preparation Sales by Application (2027-2032) & (US$ Million) Table 59. Global Transdermal Preparation Sales Market Share in Value by Application (2027-2032) Table 60. Global Transdermal Preparation Price by Application (2027-2032) & (US$/unit) Table 61. North America Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 62. North America Transdermal Preparation Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 64. Europe Transdermal Preparation Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Transdermal Preparation Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 68. Latin America Transdermal Preparation Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Transdermal Preparation Sales by Application (2021-2026) & (US$ Million) Table 71. Novastage Pharmaceuticals (Shenzhen) Company Information Table 72. Novastage Pharmaceuticals (Shenzhen) Business Overview Table 73. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio Table 75. Novastage Pharmaceuticals (Shenzhen) Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Transdermal Preparation Product Portfolio Table 80. Novartis Recent Development Table 81. Luye Pharma Group Company Information Table 82. Luye Pharma Group Business Overview Table 83. Luye Pharma Group Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Luye Pharma Group Transdermal Preparation Product Portfolio Table 85. Luye Pharma Group Recent Development Table 86. Hunan Jiudian Pharmaceutical Company Information Table 87. Hunan Jiudian Pharmaceutical Business Overview Table 88. Hunan Jiudian Pharmaceutical Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio Table 90. Hunan Jiudian Pharmaceutical Recent Development Table 91. Harbin Hexinotai Pharmaceutical Technology Company Information Table 92. Harbin Hexinotai Pharmaceutical Technology Business Overview Table 93. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio Table 95. Harbin Hexinotai Pharmaceutical Technology Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GSK Transdermal Preparation Product Portfolio Table 100. GSK Recent Development Table 101. Demo Technology Company Information Table 102. Demo Technology Business Overview Table 103. Demo Technology Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Demo Technology Transdermal Preparation Product Portfolio Table 105. Demo Technology Recent Development Table 106. Guangzhou Continent Biomedical Technology Company Information Table 107. Guangzhou Continent Biomedical Technology Business Overview Table 108. Guangzhou Continent Biomedical Technology Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio Table 110. Guangzhou Continent Biomedical Technology Recent Development Table 111. Beijing Tide Pharmaceutical Company Information Table 112. Beijing Tide Pharmaceutical Business Overview Table 113. Beijing Tide Pharmaceutical Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio Table 115. Beijing Tide Pharmaceutical Recent Development Table 116. Viatris Company Information Table 117. Viatris Business Overview Table 118. Viatris Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Viatris Transdermal Preparation Product Portfolio Table 120. Viatris Recent Development Table 121. Transdermal Corporation Company Information Table 122. Transdermal Corporation Business Overview Table 123. Transdermal Corporation Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Transdermal Corporation Transdermal Preparation Product Portfolio Table 125. Transdermal Corporation Recent Development Table 126. Nitto Company Information Table 127. Nitto Business Overview Table 128. Nitto Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Nitto Transdermal Preparation Product Portfolio Table 130. Nitto Recent Development Table 131. MEDRx Company Information Table 132. MEDRx Business Overview Table 133. MEDRx Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. MEDRx Transdermal Preparation Product Portfolio Table 135. MEDRx Recent Development Table 136. Medpharm Company Information Table 137. Medpharm Business Overview Table 138. Medpharm Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Medpharm Transdermal Preparation Product Portfolio Table 140. Medpharm Recent Development Table 141. ERCO Pharma Company Information Table 142. ERCO Pharma Business Overview Table 143. ERCO Pharma Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. ERCO Pharma Transdermal Preparation Product Portfolio Table 145. ERCO Pharma Recent Development Table 146. 4P Therapeutics Company Information Table 147. 4P Therapeutics Business Overview Table 148. 4P Therapeutics Transdermal Preparation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. 4P Therapeutics Transdermal Preparation Product Portfolio Table 150. 4P Therapeutics Recent Development Table 151. North America Transdermal Preparation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. North America Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 153. North America Transdermal Preparation Sales Market Share by Country (2021-2026) Table 154. North America Transdermal Preparation Sales Forecast by Country (2027-2032) & (k units) Table 155. North America Transdermal Preparation Sales Market Share Forecast by Country (2027-2032) Table 156. North America Transdermal Preparation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Transdermal Preparation Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Transdermal Preparation Market Share by Country (2021-2026) Table 159. North America Transdermal Preparation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Transdermal Preparation Market Share Forecast by Country (2027-2032) Table 161. Europe Transdermal Preparation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Europe Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 163. Europe Transdermal Preparation Sales Market Share by Country (2021-2026) Table 164. Europe Transdermal Preparation Sales Forecast by Country (2027-2032) & (k units) Table 165. Europe Transdermal Preparation Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Transdermal Preparation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Transdermal Preparation Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Transdermal Preparation Market Share by Country (2021-2026) Table 169. Europe Transdermal Preparation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Transdermal Preparation Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Transdermal Preparation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 173. Asia-Pacific Transdermal Preparation Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Transdermal Preparation Sales Forecast by Country (2027-2032) & (k units) Table 175. Asia-Pacific Transdermal Preparation Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Transdermal Preparation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Transdermal Preparation Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Transdermal Preparation Market Share by Country (2021-2026) Table 179. Asia-Pacific Transdermal Preparation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Transdermal Preparation Market Share Forecast by Country (2027-2032) Table 181. Latin America Transdermal Preparation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Latin America Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 183. Latin America Transdermal Preparation Sales Market Share by Country (2021-2026) Table 184. Latin America Transdermal Preparation Sales Forecast by Country (2027-2032) & (k units) Table 185. Latin America Transdermal Preparation Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Transdermal Preparation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Transdermal Preparation Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Transdermal Preparation Market Share by Country (2021-2026) Table 189. Latin America Transdermal Preparation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Transdermal Preparation Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Transdermal Preparation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 193. Middle East and Africa Transdermal Preparation Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Transdermal Preparation Sales Forecast by Country (2027-2032) & (k units) Table 195. Middle East and Africa Transdermal Preparation Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Transdermal Preparation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Transdermal Preparation Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Transdermal Preparation Market Share by Country (2021-2026) Table 199. Middle East and Africa Transdermal Preparation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Transdermal Preparation Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Transdermal Preparation Distributors List Table 204. Transdermal Preparation Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Transdermal Preparation Image Figure 2. Global Transdermal Preparation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Preparation Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Preparation Sales (2021-2032) & (k units) Figure 5. Injectable Preparations Image Figure 6. Global Injectable Preparations Sales YoY Growth (2021-2032) & (k units) Figure 7. Non Injectable Preparations Image Figure 8. Global Non Injectable Preparations Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Transdermal Preparation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Transdermal Preparation Market Share by Type 2025 VS 2032 Figure 11. North America Transdermal Preparation Sales Market Share in Volume by Type in 2025 Figure 12. North America Transdermal Preparation Sales Market Share in Value by Type in 2025 Figure 13. Europe Transdermal Preparation Sales Market Share in Volume by Type in 2025 Figure 14. Europe Transdermal Preparation Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Transdermal Preparation Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Transdermal Preparation Sales Market Share in Value by Type in 2025 Figure 17. Latin America Transdermal Preparation Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Transdermal Preparation Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Transdermal Preparation Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Transdermal Preparation Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Transdermal Preparation Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Transdermal Preparation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Transdermal Preparation Market Share by Application 2025 VS 2032 Figure 31. North America Transdermal Preparation Sales Market Share in Volume by Application in 2025 Figure 32. North America Transdermal Preparation Sales Market Share in Value by Application in 2025 Figure 33. Europe Transdermal Preparation Sales Market Share in Volume by Application in 2025 Figure 34. Europe Transdermal Preparation Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Transdermal Preparation Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Transdermal Preparation Sales Market Share in Value by Application in 2025 Figure 37. Latin America Transdermal Preparation Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Transdermal Preparation Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Transdermal Preparation Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Transdermal Preparation Sales Market Share in Value by Application in 2025 Figure 41. North America Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Transdermal Preparation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Transdermal Preparation Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Transdermal Preparation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Transdermal Preparation Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Transdermal Preparation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Transdermal Preparation Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Transdermal Preparation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Transdermal Preparation Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Transdermal Preparation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Transdermal Preparation Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Transdermal Preparation Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Transdermal Preparation Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Preparations
  • Non Injectable Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novastage Pharmaceuticals (Shenzhen)
  • Novartis
  • Luye Pharma Group
  • Hunan Jiudian Pharmaceutical
  • Harbin Hexinotai Pharmaceutical Technology
  • GSK
  • Demo Technology
  • Guangzhou Continent Biomedical Technology
  • Beijing Tide Pharmaceutical
  • Viatris
  • Transdermal Corporation
  • Nitto
  • MEDRx
  • Medpharm
  • ERCO Pharma
  • 4P Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Preparation Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transdermal Preparation Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transdermal Preparation Market by Type
  6. 1.3.1 Injectable Preparations
  7. 1.3.2 Non Injectable Preparations
  8. 1.4 Global Transdermal Preparation Market Size by Type
  9. 1.4.1 Global Transdermal Preparation Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Transdermal Preparation Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Transdermal Preparation Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Transdermal Preparation Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Transdermal Preparation Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Transdermal Preparation Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Transdermal Preparation Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Transdermal Preparation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transdermal Preparation Industry Trends
  2. 2.2 Transdermal Preparation Industry Drivers
  3. 2.3 Transdermal Preparation Industry Opportunities and Challenges
  4. 2.4 Transdermal Preparation Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transdermal Preparation Revenue (2021-2026)
  2. 3.2 Global Top Players by Transdermal Preparation Sales (2021-2026)
  3. 3.3 Global Top Players by Transdermal Preparation Price (2021-2026)
  4. 3.4 Global Transdermal Preparation Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Preparation Major Company Production Sites & Headquarters
  6. 3.6 Global Transdermal Preparation Company, Product Type & Application
  7. 3.7 Global Transdermal Preparation Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Preparation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Preparation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Preparation Tier 1, Tier 2, and Tier 3
4 Transdermal Preparation Regional Status and Outlook
  1. 4.1 Global Transdermal Preparation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transdermal Preparation Historic Market Size by Region
  3. 4.2.1 Global Transdermal Preparation Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transdermal Preparation Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transdermal Preparation Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transdermal Preparation Forecasted Market Size by Region
  7. 4.3.1 Global Transdermal Preparation Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transdermal Preparation Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transdermal Preparation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transdermal Preparation by Application
  1. 5.1 Transdermal Preparation Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Transdermal Preparation Market Size by Application
  6. 5.2.1 Global Transdermal Preparation Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Transdermal Preparation Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Transdermal Preparation Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Transdermal Preparation Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Transdermal Preparation Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Transdermal Preparation Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Transdermal Preparation Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Transdermal Preparation Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novastage Pharmaceuticals (Shenzhen)
  2. 6.1.1 Novastage Pharmaceuticals (Shenzhen) Company Information
  3. 6.1.2 Novastage Pharmaceuticals (Shenzhen) Business Overview
  4. 6.1.3 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio
  6. 6.1.5 Novastage Pharmaceuticals (Shenzhen) Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Transdermal Preparation Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Luye Pharma Group
  14. 6.3.1 Luye Pharma Group Company Information
  15. 6.3.2 Luye Pharma Group Business Overview
  16. 6.3.3 Luye Pharma Group Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Luye Pharma Group Transdermal Preparation Product Portfolio
  18. 6.3.5 Luye Pharma Group Recent Developments
  19. 6.4 Hunan Jiudian Pharmaceutical
  20. 6.4.1 Hunan Jiudian Pharmaceutical Company Information
  21. 6.4.2 Hunan Jiudian Pharmaceutical Business Overview
  22. 6.4.3 Hunan Jiudian Pharmaceutical Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio
  24. 6.4.5 Hunan Jiudian Pharmaceutical Recent Developments
  25. 6.5 Harbin Hexinotai Pharmaceutical Technology
  26. 6.5.1 Harbin Hexinotai Pharmaceutical Technology Company Information
  27. 6.5.2 Harbin Hexinotai Pharmaceutical Technology Business Overview
  28. 6.5.3 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio
  30. 6.5.5 Harbin Hexinotai Pharmaceutical Technology Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Transdermal Preparation Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Demo Technology
  38. 6.7.1 Demo Technology Company Information
  39. 6.7.2 Demo Technology Business Overview
  40. 6.7.3 Demo Technology Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Demo Technology Transdermal Preparation Product Portfolio
  42. 6.7.5 Demo Technology Recent Developments
  43. 6.8 Guangzhou Continent Biomedical Technology
  44. 6.8.1 Guangzhou Continent Biomedical Technology Company Information
  45. 6.8.2 Guangzhou Continent Biomedical Technology Business Overview
  46. 6.8.3 Guangzhou Continent Biomedical Technology Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio
  48. 6.8.5 Guangzhou Continent Biomedical Technology Recent Developments
  49. 6.9 Beijing Tide Pharmaceutical
  50. 6.9.1 Beijing Tide Pharmaceutical Company Information
  51. 6.9.2 Beijing Tide Pharmaceutical Business Overview
  52. 6.9.3 Beijing Tide Pharmaceutical Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio
  54. 6.9.5 Beijing Tide Pharmaceutical Recent Developments
  55. 6.10 Viatris
  56. 6.10.1 Viatris Company Information
  57. 6.10.2 Viatris Business Overview
  58. 6.10.3 Viatris Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Viatris Transdermal Preparation Product Portfolio
  60. 6.10.5 Viatris Recent Developments
  61. 6.11 Transdermal Corporation
  62. 6.11.1 Transdermal Corporation Company Information
  63. 6.11.2 Transdermal Corporation Business Overview
  64. 6.11.3 Transdermal Corporation Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Transdermal Corporation Transdermal Preparation Product Portfolio
  66. 6.11.5 Transdermal Corporation Recent Developments
  67. 6.12 Nitto
  68. 6.12.1 Nitto Company Information
  69. 6.12.2 Nitto Business Overview
  70. 6.12.3 Nitto Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Nitto Transdermal Preparation Product Portfolio
  72. 6.12.5 Nitto Recent Developments
  73. 6.13 MEDRx
  74. 6.13.1 MEDRx Company Information
  75. 6.13.2 MEDRx Business Overview
  76. 6.13.3 MEDRx Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 MEDRx Transdermal Preparation Product Portfolio
  78. 6.13.5 MEDRx Recent Developments
  79. 6.14 Medpharm
  80. 6.14.1 Medpharm Company Information
  81. 6.14.2 Medpharm Business Overview
  82. 6.14.3 Medpharm Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Medpharm Transdermal Preparation Product Portfolio
  84. 6.14.5 Medpharm Recent Developments
  85. 6.15 ERCO Pharma
  86. 6.15.1 ERCO Pharma Company Information
  87. 6.15.2 ERCO Pharma Business Overview
  88. 6.15.3 ERCO Pharma Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 ERCO Pharma Transdermal Preparation Product Portfolio
  90. 6.15.5 ERCO Pharma Recent Developments
  91. 6.16 4P Therapeutics
  92. 6.16.1 4P Therapeutics Company Information
  93. 6.16.2 4P Therapeutics Business Overview
  94. 6.16.3 4P Therapeutics Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 4P Therapeutics Transdermal Preparation Product Portfolio
  96. 6.16.5 4P Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Transdermal Preparation Sales by Country
  2. 7.1.1 North America Transdermal Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transdermal Preparation Sales by Country (2021-2026)
  4. 7.1.3 North America Transdermal Preparation Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transdermal Preparation Market Size by Country
  6. 7.2.1 North America Transdermal Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transdermal Preparation Market Size by Country (2021-2026)
  8. 7.2.3 North America Transdermal Preparation Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transdermal Preparation Sales by Country
  2. 8.1.1 Europe Transdermal Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transdermal Preparation Sales by Country (2021-2026)
  4. 8.1.3 Europe Transdermal Preparation Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transdermal Preparation Market Size by Country
  6. 8.2.1 Europe Transdermal Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transdermal Preparation Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transdermal Preparation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transdermal Preparation Sales by Country
  2. 9.1.1 Asia-Pacific Transdermal Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transdermal Preparation Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transdermal Preparation Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transdermal Preparation Market Size by Country
  6. 9.2.1 Asia-Pacific Transdermal Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transdermal Preparation Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transdermal Preparation Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transdermal Preparation Sales by Country
  2. 10.1.1 South America Transdermal Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transdermal Preparation Sales by Country (2021-2026)
  4. 10.1.3 South America Transdermal Preparation Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transdermal Preparation Market Size by Country
  6. 10.2.1 South America Transdermal Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transdermal Preparation Market Size by Country (2021-2026)
  8. 10.2.3 South America Transdermal Preparation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transdermal Preparation Sales by Country
  2. 11.1.1 Middle East and Africa Transdermal Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transdermal Preparation Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transdermal Preparation Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transdermal Preparation Market Size by Country
  6. 11.2.1 Middle East and Africa Transdermal Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transdermal Preparation Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transdermal Preparation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transdermal Preparation Value Chain Analysis
  2. 12.1.1 Transdermal Preparation Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transdermal Preparation Production Mode & Process
  7. 12.2 Transdermal Preparation Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transdermal Preparation Distributors
  10. 12.2.3 Transdermal Preparation Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst